PRINCIPIA BIOPHARMA INC's ticker is PRNB and the CUSIP is 74257L108. A total of 9 filers reported holding PRINCIPIA BIOPHARMA INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $589,895,000 | +255.9% | 5,896 | +112.7% | 0.00% | – |
| Q2 2020 | $165,738,000 | -86.3% | 2,772 | -86.4% | 0.00% | -100.0% |
| Q1 2020 | $1,209,808,000 | +933.0% | 20,374 | +852.9% | 0.00% | – |
| Q4 2019 | $117,120,000 | +119.8% | 2,138 | +13.3% | 0.00% | – |
| Q3 2019 | $53,289,000 | +117.6% | 1,887 | +155.7% | 0.00% | – |
| Q2 2019 | $24,494,000 | -39.3% | 738 | -37.8% | 0.00% | – |
| Q1 2019 | $40,358,000 | – | 1,187 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Leaf Venture Partners, L.L.C. | 1,996,588 | $56,384,000 | 17.05% |
| Samsara BioCapital, LLC | 383,480 | $10,829,000 | 7.37% |
| Sofinnova Investments, Inc. | 1,417,258 | $40,023,000 | 3.62% |
| Cormorant Asset Management, LP | 1,341,896 | $37,895,000 | 2.31% |
| Orbimed Advisors | 1,605,713 | $45,345,000 | 0.86% |
| Redmile Group, LLC | 790,006 | $22,310,000 | 0.75% |
| PFM Health Sciences, LP | 559,553 | $15,802,000 | 0.47% |
| RTW INVESTMENTS, LP | 270,948 | $7,652,000 | 0.46% |
| Baker Brothers Advisors | 1,654,029 | $46,710,000 | 0.32% |
| UNIVERSITY OF NOTRE DAME DU LAC | 24,572 | $694,000 | 0.21% |